Cardiovascular Biomarkers May Enhance Risk Stratification in Primary Prevention, but Evidence for Routine Clinical Use Remains Limited
Everything Has Changed About How We Treat High Blood Pressure: Game-Changing Updates & Key Insights for Clinicians from the 2025 ACC/AHA High Blood Pressure Guidelines